HOME >> BIOLOGY >> NEWS
Millennium Clones Diet-Induced Obesity Gene

CAMBRIDGE, Mass. March 11, 1999 -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) has cloned the first gene that can suppress diet-induced obesity in mice. The gene may have strong implications in developing therapies to intervene in human obesity, the authors note in their report, which appears in the March 11, 1999 issue of Nature.

The scientists found that while the gene, called mahogany (mg), produces a protein (MG) in many tissues of the body, its activity in a specific region of the brain's hypothalamus is particularly interesting because of that region's role in body weight regulation.

"The cloning of the mahogany gene and the identification of its protein product are major first steps in achieving a better understanding of their roles in controlling weight based on the amount of fat in a diet," said Karen Moore, Ph.D., director of genetic systems at Millennium. Because of the great similarity between mouse and human metabolism, the scientists expect to find that the gene plays a similar role in people.

Mice with a mutation in their mg gene maintain a healthy weight whether they eat a high fat (42 percent fat) or low fat (9 percent fat) diet with the same amount of calories. In contrast, mice with a normal mg gene gain excess weight on the high fat diet. Such diet-induced obesity differs from forms of genetically-induced obesity in which weight gain occurs even when mice are fed a normal diet. Genetically induced obesity in mice has been linked to mutations in the obese (ob), diabetes (db), tubby (tub), fat (fat) and agouti-yellow (Ay) genes. Mice with a mutation in their mg gene can suppress the genetic induced obesity of agouti-yellow mice but not that of ob, db, tub and fat mice.

The structure of the large MG protein is complex and can occur in two major forms. One form spans the cell wall leaving multiple sections of the protein to project outside the cell, which may function as receptors to which small proteins called peptide
'"/>

Contact: Marion E. Glick
m.glick@noonanrusso.com
212-696-4455 x221
Noonan/Russo Communications
11-Mar-1999


Page: 1 2 3 4

Related biology news :

1. Millenniums LDP(PS)-341 inhibits growth and induces death of cancer cells, appears to overcome chemotherapy resistance
2. Millennium and Bayer industrializing drug discovery process through ongoing successful research alliance
3. Science and Technology at the Millennium: Retrospect or Prospect Focus of AAAS Science and Technology Colloquium, April 11-13 in Washington, DC
4. Millennium and Wyeth-Ayerst announce the discovery of key potassium ion channel modulating proteins
5. Millennium and the Whitehead Institute identify novel protein important in fat absorption
6. Allelix Clones Receptor For Intestinal Growth Factor GLP-2
7. International Research Team Clones New Skin Cancer Gene
8. Obesity and hypertension: Two epidemics or one?
9. Obesity alone not a good predictor of cardiovascular risk and death, fat distribution proved best
10. Obesity drug inhibits prostate tumor growth
11. Obesity and blood pressure

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
(Date:3/30/2017)... YORK , March 30, 2017 Trends, ... type (physiological and behavioral), by technology (fingerprint, AFIS, iris ... voice recognition, and others), by end use industry (government ... and immigration, financial and banking, and others), and by ... Europe , Asia Pacific , ...
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... and PETACH TIKVAH, Israel , April 20, ... developer of adult stem cell technologies for neurodegenerative diseases, announced ... present at the Alliance for Regenerative Medicine,s (ARM) 5 th ... April 27, 2017 at 09:40 EDT in Boston ... , MD, MHSc, Chief Medical Officer & Chief Operating Officer, ...
(Date:4/19/2017)... ... April 18, 2017 , ... ... Labs . The move comes after the company changed focus to making analytical ... new brand and our new technology,” says CEO Robert Hart. Founders Bernardo Cordovez, ...
(Date:4/19/2017)... Oregon and PUNE, India , April 19, 2017 ... "Membrane Microfiltration Market: Global Opportunity Analysis and Industry Forecast, 2014-2022 ," the ... garner $12,858 million by 2022, registering a CAGR of 9.6% from 2016 to ... ... ...
(Date:4/18/2017)... ... April 18, 2017 , ... METTLER TOLEDO ... to concentration levels and vice-versa. , One of the key applications for the ... concentration control or monitoring. The principle of this analytical method is based on ...
Breaking Biology Technology:
Cached News: